Hunan Jiudian Pharmaceutical Co., Ltd. (300705.SZ)
CNY 16.46
(-0.72%)
CNY 16.46
(-0.72%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 429.88 Million CNY | 35.85% |
| 2022 | 316.44 Million CNY | -3.69% |
| 2021 | 328.57 Million CNY | 271.6% |
| 2020 | 88.42 Million CNY | -36.91% |
| 2019 | 140.15 Million CNY | 75.88% |
| 2018 | 79.68 Million CNY | 1892.24% |
| 2017 | 4 Million CNY | -80.0% |
| 2016 | 20 Million CNY | 0.0% |
| 2015 | 20 Million CNY | 33.33% |
| 2014 | 15 Million CNY | -50.0% |
| 2013 | 30 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 440.96 Million CNY | 12.18% |
| 2024 Q3 | 361.2 Million CNY | -18.09% |
| 2024 Q1 | 393.07 Million CNY | -8.56% |
| 2023 Q1 | 367.2 Million CNY | 16.04% |
| 2023 Q2 | 357.29 Million CNY | -2.7% |
| 2023 Q4 | 429.88 Million CNY | -32.12% |
| 2023 Q3 | 633.32 Million CNY | 77.26% |
| 2023 FY | 429.88 Million CNY | 35.85% |
| 2022 Q1 | 330.6 Million CNY | 0.62% |
| 2022 Q2 | 333.34 Million CNY | 0.83% |
| 2022 Q3 | 441.42 Million CNY | 32.42% |
| 2022 Q4 | 316.44 Million CNY | -28.31% |
| 2022 FY | 316.44 Million CNY | -3.69% |
| 2021 Q2 | 308.25 Million CNY | 188.41% |
| 2021 Q4 | 328.57 Million CNY | 1.62% |
| 2021 Q3 | 323.35 Million CNY | 4.9% |
| 2021 FY | 328.57 Million CNY | 271.6% |
| 2021 Q1 | 106.88 Million CNY | 20.88% |
| 2020 Q4 | 88.42 Million CNY | 10.18% |
| 2020 Q3 | 80.25 Million CNY | -31.1% |
| 2020 Q1 | 133.66 Million CNY | -4.63% |
| 2020 FY | 88.42 Million CNY | -36.91% |
| 2020 Q2 | 116.46 Million CNY | -12.87% |
| 2019 FY | 140.15 Million CNY | 75.88% |
| 2019 Q3 | 126.83 Million CNY | 44.46% |
| 2019 Q2 | 87.79 Million CNY | 49.44% |
| 2019 Q1 | 58.74 Million CNY | -26.28% |
| 2019 Q4 | 140.15 Million CNY | 10.5% |
| 2018 Q2 | 40 Million CNY | 900.0% |
| 2018 Q3 | 40 Million CNY | 0.0% |
| 2018 Q4 | 79.68 Million CNY | 99.22% |
| 2018 FY | 79.68 Million CNY | 1892.24% |
| 2018 Q1 | 4 Million CNY | 0.0% |
| 2017 Q4 | 4 Million CNY | -73.33% |
| 2017 FY | 4 Million CNY | -80.0% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q3 | 15 Million CNY | 0.0% |
| 2017 Q2 | 15 Million CNY | 0.0% |
| 2016 Q1 | 30 Million CNY | 50.0% |
| 2016 Q3 | - CNY | -100.0% |
| 2016 Q2 | 40 Million CNY | 33.33% |
| 2016 Q4 | 20 Million CNY | 0.0% |
| 2016 FY | 20 Million CNY | 0.0% |
| 2015 Q2 | 10 Million CNY | 0.0% |
| 2015 FY | 20 Million CNY | 33.33% |
| 2015 Q4 | 20 Million CNY | 0.0% |
| 2015 Q3 | 20 Million CNY | 100.0% |
| 2015 Q1 | 10 Million CNY | -33.33% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q4 | 15 Million CNY | 0.0% |
| 2014 Q3 | 15 Million CNY | 0.0% |
| 2014 FY | 15 Million CNY | -50.0% |
| 2013 FY | 30 Million CNY | 0.0% |